Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Novartis Ag Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,534 shares of NVS stock, worth $202,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,534
Previous 1,874
18.14%
Holding current value
$202,165
Previous $208,000
11.06%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,563Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$996 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$939 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...